Institutional Ownership Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO). We have compiled data on the 243 institutions that hold shares in the stock, with a total of 59.9 Million shares, which have been reported (via 13F filing form) to have a value of $1.87 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
567,170
shares
|
$18.3 Million
0.0% of portfolio
|
Q4 2024
Added 18.99%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
516,475
shares
|
$16.7 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.99%
|
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Feb 12, 2025 Q4 2024 |
499,134
shares
|
$16.1 Million
0.03% of portfolio
|
Q4 2024
Added 27.38%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
472,547
shares
|
$15.3 Million
0.0% of portfolio
|
Q4 2024
Added 1.49%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
471,086
shares
|
$15.2 Million
0.62% of portfolio
|
Q4 2024
Reduced 32.64%
|
|
|
Loomis Sayles & CO L P
|
Feb 12, 2025 Q4 2024 |
417,208
shares
|
$13.5 Million
0.02% of portfolio
|
Q4 2024
Reduced 31.87%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
404,902
shares
|
$13.1 Million
0.0% of portfolio
|
Q4 2024
Added 21.56%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
378,089
shares
|
$12.2 Million
0.0% of portfolio
|
Q4 2024
Added 8.34%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
354,455
shares
|
$11.5 Million
0.01% of portfolio
|
Q4 2024
Reduced 11.57%
|
|
|
Eagle Health Investments LP
Greenwich, CT |
Feb 12, 2025 Q4 2024 |
330,830
shares
|
$10.7 Million
2.67% of portfolio
|
Q4 2023
Added 23.61%
|
|
|
Center Book Partners LP
Greenwich, CT |
Feb 13, 2025 Q4 2024 |
305,599
shares
|
$9.87 Million
0.65% of portfolio
|
Q4 2024
Added 98.33%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
303,000
shares
|
$9.79 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
Cutter Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
301,623
shares
|
$9.75 Million
4.06% of portfolio
|
Q4 2024
Added 61.62%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
276,439
shares
|
$8.93 Million
0.35% of portfolio
|
Q4 2024
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
251,774
shares
|
$8.13 Million
0.25% of portfolio
|
Q4 2024
Added 8.03%
|
|
|
Casdin Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
250,000
shares
|
$8.08 Million
0.71% of portfolio
|
Q4 2024
New holding
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
248,038
shares
|
$8.01 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
234,343
shares
|
$7.57 Million
0.0% of portfolio
|
Q4 2024
Added 105.23%
|
|
|
Nordea Investment Management Ab
Stockholm, V7 |
Jan 06, 2025 Q4 2024 |
220,569
shares
|
$7.13 Million
0.01% of portfolio
|
Q4 2024
Added 3.57%
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
214,027
shares
|
$6.92 Million
0.0% of portfolio
|
Q4 2024
Added 69.18%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Feb 14, 2025 Q4 2024 |
200,481
shares
|
$6.48 Million
0.03% of portfolio
|
Q4 2024
Added 2.08%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
199,970
shares
|
$6.46 Million
0.01% of portfolio
|
Q4 2024
Added 136.88%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
199,538
shares
|
$6.45 Million
0.02% of portfolio
|
Q4 2024
Added 38.55%
|
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
193,152
shares
|
$6.24 Million
0.0% of portfolio
|
Q4 2024
Added 168.03%
|
|
|
Axa S.A.
Paris, I0 |
Feb 14, 2025 Q4 2024 |
175,377
shares
|
$5.67 Million
0.02% of portfolio
|
Q2 2024
Added 36.1%
|